Press coverage about Walgreens Boots Alliance (NASDAQ:WBA) has trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a news impact score of 0.16 on Accern’s scale. Accern also gave headlines about the pharmacy operator an impact score of 45.9157853199944 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:
- Walgreens Boots Alliance Inc (WBA) Forecasted to Earn Q2 2018 Earnings of $1.59 Per Share (americanbankingnews.com)
- Why I’m Still Bullish on a Rite Aid Corporation Stock Turnaround (finance.yahoo.com)
- How Walgreens’s International Businesses Performed in 1Q18 (finance.yahoo.com)
- Rite Aid (RAD) Soars Too High Too Fast: Is This Justified? (finance.yahoo.com)
- Walgreens Boots Alliance to Webcast Annual Meeting of Stockholders (finance.yahoo.com)
Walgreens Boots Alliance (NASDAQ:WBA) traded up $1.25 on Thursday, reaching $75.33. 6,300,000 shares of the company traded hands, compared to its average volume of 6,500,000. The stock has a market capitalization of $74,600.00, a PE ratio of 20.81, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48.
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.12%. Walgreens Boots Alliance’s payout ratio is 44.20%.
Walgreens Boots Alliance declared that its board has approved a stock buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.
A number of brokerages have recently issued reports on WBA. Needham & Company LLC reissued a “buy” rating and issued a $88.00 price objective (up from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. Robert W. Baird reissued an “outperform” rating and issued a $80.00 price objective (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Finally, Royal Bank of Canada began coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Nine analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Walgreens Boots Alliance currently has an average rating of “Buy” and an average price target of $86.15.
In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of the stock in a transaction on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance (WBA) Getting Somewhat Favorable Press Coverage, Accern Reports” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.com-unik.info/2018/01/11/walgreens-boots-alliance-wba-getting-somewhat-favorable-press-coverage-accern-reports.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
What are top analysts saying about Walgreens Boots Alliance? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance and related companies.